Search for other papers by V Guarnotta in
Google Scholar
PubMed
Search for other papers by C Di Stefano in
Google Scholar
PubMed
Search for other papers by A Santoro in
Google Scholar
PubMed
Search for other papers by A Ciresi in
Google Scholar
PubMed
Search for other papers by A Coppola in
Google Scholar
PubMed
Search for other papers by C Giordano in
Google Scholar
PubMed
deficiency combinations are shown in Table 1 . Patients with hypothyroidism were treated with levo-thyroxine at the average dose of 1 µg/kg. Patients with GHD were treated with somatotropin at the average dose of 0.4 mg/day. Males with hypogonadism were
Search for other papers by Christin Krause in
Google Scholar
PubMed
Search for other papers by Martina Grohs in
Google Scholar
PubMed
Search for other papers by Alexander T El Gammal in
Google Scholar
PubMed
Search for other papers by Stefan Wolter in
Google Scholar
PubMed
Search for other papers by Hendrik Lehnert in
Google Scholar
PubMed
Search for other papers by Oliver Mann in
Google Scholar
PubMed
Search for other papers by Jens Mittag in
Google Scholar
PubMed
Search for other papers by Henriette Kirchner in
Google Scholar
PubMed
-00433 ) 18 Bruinstroop E Dalan R Cao Y Bee YM Chandran K Cho LW Soh SB Teo EK Toh SA Leow MKS , et al . Low-dose levothyroxine reduces intrahepatic lipid content in patients with type 2 diabetes mellitus and NAFLD . Journal of Clinical Endocrinology and
Search for other papers by Fan Zhang in
Google Scholar
PubMed
Search for other papers by Jian Chen in
Google Scholar
PubMed
Search for other papers by Xinyue Lin in
Google Scholar
PubMed
Search for other papers by Shiqiao Peng in
Google Scholar
PubMed
Search for other papers by Xiaohui Yu in
Google Scholar
PubMed
Search for other papers by Zhongyan Shan in
Google Scholar
PubMed
Search for other papers by Weiping Teng in
Google Scholar
PubMed
L Yu X Teng W Shan Z. Treatment with levothyroxine in pregnant rats with subclinical hypothyroidism improves cell migration in the developing brain of the progeny . Journal of Endocrinological Investigation 2012 35 490 – 496 . ( https
Search for other papers by Eliana Piantanida in
Google Scholar
PubMed
Search for other papers by Daniela Gallo in
Google Scholar
PubMed
Research Center in Epidemiology and Preventive Medicine (EPIMED), University of Insubria, Varese, Italy
Search for other papers by Giovanni Veronesi in
Google Scholar
PubMed
Search for other papers by Eugenia Dozio in
Google Scholar
PubMed
Search for other papers by Eugenia Trotti in
Google Scholar
PubMed
Search for other papers by Adriana Lai in
Google Scholar
PubMed
Search for other papers by Silvia Ippolito in
Google Scholar
PubMed
Search for other papers by Jessica Sabatino in
Google Scholar
PubMed
Search for other papers by Maria Laura Tanda in
Google Scholar
PubMed
Search for other papers by Antonio Toniolo in
Google Scholar
PubMed
Research Center in Epidemiology and Preventive Medicine (EPIMED), University of Insubria, Varese, Italy
Search for other papers by Marco Ferrario in
Google Scholar
PubMed
Search for other papers by Luigi Bartalena in
Google Scholar
PubMed
.0 – – Other medications (%) Levothyroxine 10 (17.2%) 19 (21.1%) 8 (23.5%) 0.7 – – Allopurinol 8 (13.3%) 3 (3.1%) 3 (7.5%) 0.055 – – Mean TSH levels ( s.d. ) (U/L) 2.4 (2) 3 (9) 2.4 (2) 0
Search for other papers by Xiaowen Zhang in
Google Scholar
PubMed
Department of Endocrinology and Metabolism, Drum Tower Clinical Medical College, Southeast University, Nanjing, China
Search for other papers by Chen Han in
Google Scholar
PubMed
Search for other papers by Hongwei Wang in
Google Scholar
PubMed
Search for other papers by Xinghong Sun in
Google Scholar
PubMed
Search for other papers by Xin Dou in
Google Scholar
PubMed
Search for other papers by Xueying He in
Google Scholar
PubMed
Search for other papers by Di Wu in
Google Scholar
PubMed
Search for other papers by Shanmei Shen in
Google Scholar
PubMed
Search for other papers by Dalong Zhu in
Google Scholar
PubMed
Search for other papers by Xinlin Zhang in
Google Scholar
PubMed
Search for other papers by Yan Bi in
Google Scholar
PubMed
they were enrolled were methimazole (in 67 patients, median dose 10 mg), propylthiouracil (in 1 patient, dose 150 mg), levothyroxine (in 10 patients, median dose 75 μg), and others were not on antithyroid medications or hormones. No patient was on
Department of Psychology II, University of Lübeck, Lübeck, Germany
Search for other papers by Marcus Heldmann in
Google Scholar
PubMed
Search for other papers by Krishna Chatterjee in
Google Scholar
PubMed
Search for other papers by Carla Moran in
Google Scholar
PubMed
Search for other papers by Berenike Rogge in
Google Scholar
PubMed
Search for other papers by Julia Steinhardt in
Google Scholar
PubMed
Search for other papers by Tobias Wagner-Altendorf in
Google Scholar
PubMed
Search for other papers by Martin Göttlich in
Google Scholar
PubMed
Search for other papers by Hannes Schacht in
Google Scholar
PubMed
Search for other papers by Peter Schramm in
Google Scholar
PubMed
Department of Endocrinology, The Christie, University of Manchester, Manchester, UK
Search for other papers by Georg Brabant in
Google Scholar
PubMed
Department of Psychology II, University of Lübeck, Lübeck, Germany
Search for other papers by Thomas F Münte in
Google Scholar
PubMed
Search for other papers by Anna Cirkel in
Google Scholar
PubMed
levothyroxine therapy of primary hypothyroidism . Fertility and Sterility 1983 40 389 – 392 . ( https://doi.org/10.1016/s0015-0282(1647307-3 ) 22 Al Mohareb O AlMalki MH Mueller OT Brema I . Resistance to thyroid hormone-beta co-existing with
Department of Health Sciences, University of Florence, Florence, Italy
Search for other papers by Alessandro Barbato in
Google Scholar
PubMed
Search for other papers by Giulia Gori in
Google Scholar
PubMed
Search for other papers by Michele Sacchini in
Google Scholar
PubMed
Search for other papers by Francesca Pochiero in
Google Scholar
PubMed
Search for other papers by Sara Bargiacchi in
Google Scholar
PubMed
Search for other papers by Giovanna Traficante in
Google Scholar
PubMed
Search for other papers by Viviana Palazzo in
Google Scholar
PubMed
Search for other papers by Lucia Tiberi in
Google Scholar
PubMed
Search for other papers by Claudia Bianchini in
Google Scholar
PubMed
Search for other papers by Davide Mei in
Google Scholar
PubMed
Search for other papers by Elena Parrini in
Google Scholar
PubMed
Search for other papers by Tiziana Pisano in
Google Scholar
PubMed
Search for other papers by Elena Procopio in
Google Scholar
PubMed
NEUROFARBA Department, University of Florence, Florence, Italy
Search for other papers by Renzo Guerrini in
Google Scholar
PubMed
Department of Clinical and Experimental Biomedical Sciences “Mario Serio”, University of Florence, Florence, Italy
Search for other papers by Angela Peron in
Google Scholar
PubMed
Department of Health Sciences, University of Florence, Florence, Italy
Search for other papers by Stefano Stagi in
Google Scholar
PubMed
for thyroid-specific autoimmunity were normal and thyroid ultrasound was unrevealing. Substitution therapy with levo-thyroxine (L-T 4 ) was started( 10 ). Delayed bone age based on Greulich and Pyle was observed at wrist X-ray. A growth hormone (GH
Search for other papers by Jaafar Jaafar in
Google Scholar
PubMed
Search for other papers by Eugenio Fernandez in
Google Scholar
PubMed
Search for other papers by Heba Alwan in
Google Scholar
PubMed
Search for other papers by Jacques Philippe in
Google Scholar
PubMed
levothyroxine dose doubling was necessary in 3 patients with known hypothyroidism. The median time to onset of thyroid irAEs was 6 weeks after initiation of pembrolizumab, and when recovery to a euthyroid state occurred, the median time was 6.5 weeks after
Search for other papers by Filippo Ceccato in
Google Scholar
PubMed
Search for other papers by Elisa Selmin in
Google Scholar
PubMed
Search for other papers by Chiara Sabbadin in
Google Scholar
PubMed
Search for other papers by Miriam Dalla Costa in
Google Scholar
PubMed
Search for other papers by Giorgia Antonelli in
Google Scholar
PubMed
Search for other papers by Mario Plebani in
Google Scholar
PubMed
Search for other papers by Mattia Barbot in
Google Scholar
PubMed
Search for other papers by Corrado Betterle in
Google Scholar
PubMed
Search for other papers by Marco Boscaro in
Google Scholar
PubMed
Search for other papers by Carla Scaroni in
Google Scholar
PubMed
and serum potassium levels. Hypothyroid patients were stably treated with levothyroxine to normalize TSH values (around 1–4 mIU/L) in case of primary autoimmune thyroiditis or free thyroxine levels (in the middle quartiles of normal range) in case of
Search for other papers by Elena Valassi in
Google Scholar
PubMed
Search for other papers by Natalia García-Giralt in
Google Scholar
PubMed
Search for other papers by Jorge Malouf in
Google Scholar
PubMed
Search for other papers by Iris Crespo in
Google Scholar
PubMed
Search for other papers by Jaume Llauger in
Google Scholar
PubMed
Search for other papers by Adolfo Díez-Pérez in
Google Scholar
PubMed
Search for other papers by Susan M Webb in
Google Scholar
PubMed
had secondary adrenal insufficiency, and all of them were on stable replacement dose of hydrocortisone. Five patients had secondary hypothyroidism and were on stable replacement therapy with levothyroxine at the time of the study. Four males had